STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31

Stemtech Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $207.74K
P/E (TTM): –
Dividend yield: –

Stemtech Corp income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2019 2019-08-31	FY 2018 2018-08-31	FY 2017 2017-08-31	FY 2016 2016-08-31	FY 2015 2015-08-31	FY 2014 2014-08-31	FY 2013 2013-08-31	FY 2012 2012-08-31	FY 2011 2011-08-31	FY 2010 2010-08-31
Revenue	2.88	5.05	4.92	4.56	4.32	–	–	–	–	–	–	–	–	–	–
Cost of Revenue	0.57	1.33	1.00	1.16	1.02	–	–	–	–	–	–	–	–	–	–
Gross Profit	2.31	3.73	3.92	3.40	3.30	–	–	–	–	–	–	–	–	–	–
Research & Development	0	0	0.01	0	–	–	–	–	–	–	–	–	–	–	–
Selling, General & Admin	–	–	6.94	7.37	5.49	–	–	–	–	–	–	–	–	–	–
Selling & Marketing	–	–	0.50	0.53	0.74	–	–	–	–	–	–	–	–	–	–
General & Administrative	4.55	5.23	6.44	6.84	4.75	0.02	0.02	0.04	0.02	0.02	0.04	0.03	0.03	–	–
Operating Expenses	5.02	6.11	8.14	8.42	6.51	–	–	–	–	–	–	–	–	–	–
Operating Income	-2.71	-2.39	-4.22	-5.02	-3.21	-0.02	-0.02	-0.04	-0.02	-0.02	-0.04	-0.03	-0.03	–	–
Interest Expense	1.45	1.58	4.89	–	8.33	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	–	–
Other Non-Operating Income	-1.34	-1.39	-1.21	-3.51	-3.90	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	0	0	0	–	–	–	–	–	–	–	–	–	–	–	–
Pretax Income	-4.05	-3.77	-5.43	-8.54	-7.11	–	–	–	–	–	–	–	–	–	–
Income Tax Expense	0	0	0	0.10	0	–	–	–	–	–	0	0	–	–	–
Net Income incl. Noncontrolling Interests	-4.05	-3.77	-5.43	-8.63	-7.11	–	–	–	–	–	-0.04	-0.03	-0.03	–	–
Minority Interest in Earnings	0.00	0.00	0.00	-0.09	-0.03	–	–	–	–	–	–	–	–	–	–
Net Income	-4.05	-3.77	-5.43	-8.54	-7.08	-0.03	-0.04	-0.05	-0.03	-0.02	-0.04	-0.03	-0.03	-0.02	-0.01
EPS (Basic)(per share)	-0.02	-0.03	-0.07	-0.19	-0.20	-0.0030	-0.0040	-0.0040	-0.0030	-0.0020	-0.0030	-0.0030	-0.0030	–	–
EPS (Diluted)(per share)	-0.02	-0.03	-0.07	-0.19	-0.20	-0.0030	-0.0040	-0.0040	-0.0030	-0.0020	-0.0030	-0.0030	-0.0030	–	–
Shares Outstanding (Basic, Weighted)(shares)	170	119	83	46	35	11	11	11	11	11	11	9.50	9.50	–	–
Shares Outstanding (Diluted, Weighted)(shares)	170	119	83	46	35	11	11	11	11	11	11	9.50	9.50	–	–
EBITDA	-2.54	-2.04	-3.64	-4.58	-2.78	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 77.3%
Operating margin: -100.8%
Net margin: -159.7%
Return on equity, FY2025: 70.7%

Financial strength

Current ratio: 0.05
Debt to equity: 0.00
Debt to assets: 0.0%
Cash to current liabilities: 2.2%

Valuation

P/E ratio: –
Price to sales: 0.09
Price to book: –
Dividend yield: –